LRRC37A16P

Across TCGA pan-cancer cohorts, LRRC37A16P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LRRC37A16P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LRRC37A16P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LRRC37A16P expression acts as an unfavorable survival marker, although some lineages such as KIRC and LUAD show a favorable association.

KIRC, LUAD, and MESO are the cancer types where LRRC37A16P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.714	0.549	<.001	106	view →
LUAD	DFS	Median	III,IV	0.643	0.362	.001	62	view →
MESO	DFS	Quartile	III,IV	0.251	0.551	.002	48	view →
LAML	DFS	Tertile	All	0.573	0.251	.004	30	view →
BLCA	DFS	Quartile	II,III,IV	0.410	0.562	.015	27	view →
HNSC	OS	Tertile	All	0.271	0.506	.005	18	view →
LGG	OS	Quartile	All	0.789	0.977	<.001	16	view →
READ	OS	Median	II,III,IV	0.844	0.454	.012	12	view →
KICH	DFS	Quartile	II,III,IV	0.414	0.868	.011	10	view →
BRCA	OS	Quartile	IV	0.794	0.228	.004	10	view →
CHOL	DFS	Median	All	0.727	0.227	.012	9	view →
COAD	OS	Tertile	III,IV	0.791	0.572	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LRRC37A16P–KIRC (DFS)

Open the KIRC breakdown →